Literature DB >> 22714998

A cross-sectional survey of the relationship between fecal incontinence and constipation.

Eddie H M Sze1, C Debra Barker, Gerry Hobbs.   

Abstract

INTRODUCTION AND HYPOTHESIS: We compared the prevalence of fecal incontinence between constipated and nonconstipated women and correlated its prevalence with the number of Rome III constipation symptoms.
METHODS: We performed a cross-sectional survey to evaluate the prevalence of fecal incontinence and constipation among women who presented to two gynecologic clinics for routine care over a 24-month period. Fecal incontinence was defined as loss of well-formed and/or loose stool beyond the patient's control that occurred at least once in the last 4 weeks, was bothersome, had been present for the past 3 or more months, and had affected the person's activities, relationships, or feelings. Constipation was diagnosed using the Rome III criteria. Our study was exempt from institutional review board approval because it was a survey and did not ask for information that could be used to identify the participant.
RESULTS: Mean age of the 2,319 participants was 50.1 ± 15 years and mean body mass index (BMI) was 28.7 ± 7. Seven hundred and twenty-five (31 %) women had constipation, and 233 (10 %) had fecal incontinence. One hundred and one (43 %) incontinent women had coexisting constipation. Logistic regression analysis identified white race (p = .013), menopause (p = .010), and constipation (p = .004) as risk factors for fecal incontinence. After controlling for these risk factors, constipated women were more likely to have fecal incontinence than nonconstipated women [relative risk (RR) 1.60, 95 % confidence interval (CI) 1.26-2.05]. In addition, the prevalence of fecal incontinence was strongly associated with the number of Rome III constipation symptoms (p < .001).
CONCLUSION: Constipation is an important risk factor for fecal incontinence.

Entities:  

Mesh:

Year:  2012        PMID: 22714998     DOI: 10.1007/s00192-012-1851-7

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  16 in total

1.  Results of sphincteroplasty in 86 patients with anal incontinence.

Authors:  S Karoui; A M Leroi; E Koning; J F Menard; F Michot; P Denis
Journal:  Dis Colon Rectum       Date:  2000-06       Impact factor: 4.585

Review 2.  Epidemiology of fecal incontinence.

Authors:  Richard L Nelson
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

Review 3.  Introduction. Advancing the treatment of fecal and urinary incontinence through research.

Authors:  William E Whitehead; Nancy J Norton; Arnold Wald
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

4.  Fecal incontinence in Wisconsin nursing homes: prevalence and associations.

Authors:  R Nelson; S Furner; V Jesudason
Journal:  Dis Colon Rectum       Date:  1998-10       Impact factor: 4.585

5.  Prospective comparison of faecal incontinence grading systems.

Authors:  C J Vaizey; E Carapeti; J A Cahill; M A Kamm
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

Review 6.  Clinical and economic evaluation of surgical treatments for faecal incontinence.

Authors:  A J Malouf; M G Chambers; M A Kamm
Journal:  Br J Surg       Date:  2001-08       Impact factor: 6.939

7.  Sexual function, quality of life, and severity of anal incontinence after anal sphincteroplasty.

Authors:  Elisa R Trowbridge; Daniel Morgan; Matthew J Trowbridge; John O L Delancey; Dee E Fenner
Journal:  Am J Obstet Gynecol       Date:  2006-12       Impact factor: 8.661

Review 8.  Functional anorectal disorders.

Authors:  Adil E Bharucha; Arnold Wald; Paul Enck; Satish Rao
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

9.  Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7).

Authors:  M D Barber; M D Walters; R C Bump
Journal:  Am J Obstet Gynecol       Date:  2005-07       Impact factor: 8.661

Review 10.  Medical management of fecal incontinence.

Authors:  Yolanda Scarlett
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

View more
  7 in total

1.  Racial differences in fecal incontinence in community-dwelling women from the EPI study.

Authors:  Mitchell B Berger; John O Delancey; Dee E Fenner
Journal:  Female Pelvic Med Reconstr Surg       Date:  2013 May-Jun       Impact factor: 2.091

2.  Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review.

Authors:  Ferdinando D'Amico; Steven D Wexner; Carolynne J Vaizey; Célia Gouynou; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-07-17       Impact factor: 4.623

3.  Faecal incontinence-the hidden scourge of irritable bowel syndrome: a cross-sectional study.

Authors:  Sima Atarodi; Shahram Rafieian; Peter J Whorwell
Journal:  BMJ Open Gastroenterol       Date:  2015-02-06

4.  On the prevalence of constipation and fecal incontinence, and their co-occurrence, in the Netherlands.

Authors:  Rob J Meinds; Maxime M van Meegdenburg; Monika Trzpis; Paul M A Broens
Journal:  Int J Colorectal Dis       Date:  2016-12-02       Impact factor: 2.571

5.  Prevalence and Associated Factors of Fecal Incontinence and Double Incontinence among Rural Elderly in North China.

Authors:  Yan Luo; Kai Wang; Ping Zou; Xiaomei Li; Jinjie He; Jing Wang
Journal:  Int J Environ Res Public Health       Date:  2020-12-06       Impact factor: 3.390

6.  Prevalence of faecal incontinence and its related factors among patients in a Malaysian academic setting.

Authors:  April C Roslani; Rajeshwary Ramakrishnan; Soraya Azmi; Daryl J Arapoc; Adrian Goh
Journal:  BMC Gastroenterol       Date:  2014-05-18       Impact factor: 3.067

7.  Fecal incontinence and parity in the Dutch population: A cross-sectional analysis.

Authors:  Maxime M van Meegdenburg; Monika Trzpis; Paul Ma Broens
Journal:  United European Gastroenterol J       Date:  2018-02-28       Impact factor: 4.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.